pharma · Ovarian Cancer · Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer · ANIX
Anixa Biosciences
Anixa Biosciences Inc
Anixa Biosciences patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- San Jose, USA
- Founded
- 1982
- Employees
- 12
- Programs
- 2
- Drugs
- 4
- Patents
- 1
Anixa Biosciences patents
1 pharmaceutical patents indexed for Anixa Biosciences. 0 expire within 24 months.
Anixa Biosciences has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Anixa Biosciences have?
1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Anixa Biosciences patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.